Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Double Blind, Placebo-controlled, Randomized, Multi-Center Study to Evaluate the Efficacy of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke

NCT01758536 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT01758536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01758536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Double Blind, Placebo-controlled, Randomized, Multi-Center Study to Evaluate the Efficacy of Huatuo Zaizao Pills in Improving of Neural Function in Acute Ischemic Stroke
Lead sponsor
Huashan Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2012
Completion date
December 31, 2014
Enrollment
1,100 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke